1.miR-148b inhibits M2 polarization of LPS-stimulated macrophages by targeting DcR3.
Li Yuan YANG ; Xiao Li LOU ; Yue WANG ; Yan Qiang HOU
Chinese Journal of Preventive Medicine 2023;57(8):1231-1237
		                        		
		                        			
		                        			Objective: To investigate the effect of microRNA (miR-148b) targeting decoy receptor 3 (DcR3) on macrophage polarization in sepsis. Methods: Experimental study. From December 2019 to December 2022, serum microRNA expression was detected in 3 patients with sepsis and 3 healthy controls in the clinical laboratory of Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Phorbol 12-myristate 13-acetate (PMA) was used to induce the differentiation of human acute monocytic leukemia cells THP-1 into macrophages, and then lipopolysaccharide (LPS) was added to stimulate the establishment of a sepsis cell model, and the expression changes of miR-148b and DcR3 were detected by RT-PCR and Western blot. Overexpression of DcR3 was used to detect the expression levels of TNF-α, CD163 and IL-10 in macrophages stimulated by LPS (100 ng/ml). Overexpression of miR-148b was used to observe the changes of molecular markers of macrophage polarization. The targeting regulation effect of miR-148b on DcR3 was determined by dual-luciferase reporter assay. t test was used to analyze whether there were statistical differences among the groups. Results: The expression of miR-148b was down-regulated (P<0.05) and the expression of DcR3 was up-regulated (P<0.01) in THP-1 macrophages stimulated by LPS. Overexpression of DcR3 inhibited the expression of TNF-α (P<0.05) and promoted the expression of CD163 (P<0.01) and IL-10 (P<0.01). When miR-148b mimics was added, the opposite effect was observed. The dual-luciferase reporter assay confirmed that miR-148b targets and binds to DcR3, inhibiting its transcription and expression. The results of flow cytometry showed that DcR3 could reverse the promoting effect of miR-148b on the CD86/CD163 ratio of macrophages (P<0.05). Conclusion: miR-148b inhibits the expression of DcR3, thereby inhibiting M2 polarization in LPS-stimulated macrophage cells.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			Lipopolysaccharides/pharmacology*
		                        			;
		                        		
		                        			Macrophages
		                        			;
		                        		
		                        			MicroRNAs/genetics*
		                        			;
		                        		
		                        			Receptors, Tumor Necrosis Factor, Member 6b/metabolism*
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha
		                        			
		                        		
		                        	
2.miR-148b inhibits M2 polarization of LPS-stimulated macrophages by targeting DcR3.
Li Yuan YANG ; Xiao Li LOU ; Yue WANG ; Yan Qiang HOU
Chinese Journal of Preventive Medicine 2023;57(8):1231-1237
		                        		
		                        			
		                        			Objective: To investigate the effect of microRNA (miR-148b) targeting decoy receptor 3 (DcR3) on macrophage polarization in sepsis. Methods: Experimental study. From December 2019 to December 2022, serum microRNA expression was detected in 3 patients with sepsis and 3 healthy controls in the clinical laboratory of Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Phorbol 12-myristate 13-acetate (PMA) was used to induce the differentiation of human acute monocytic leukemia cells THP-1 into macrophages, and then lipopolysaccharide (LPS) was added to stimulate the establishment of a sepsis cell model, and the expression changes of miR-148b and DcR3 were detected by RT-PCR and Western blot. Overexpression of DcR3 was used to detect the expression levels of TNF-α, CD163 and IL-10 in macrophages stimulated by LPS (100 ng/ml). Overexpression of miR-148b was used to observe the changes of molecular markers of macrophage polarization. The targeting regulation effect of miR-148b on DcR3 was determined by dual-luciferase reporter assay. t test was used to analyze whether there were statistical differences among the groups. Results: The expression of miR-148b was down-regulated (P<0.05) and the expression of DcR3 was up-regulated (P<0.01) in THP-1 macrophages stimulated by LPS. Overexpression of DcR3 inhibited the expression of TNF-α (P<0.05) and promoted the expression of CD163 (P<0.01) and IL-10 (P<0.01). When miR-148b mimics was added, the opposite effect was observed. The dual-luciferase reporter assay confirmed that miR-148b targets and binds to DcR3, inhibiting its transcription and expression. The results of flow cytometry showed that DcR3 could reverse the promoting effect of miR-148b on the CD86/CD163 ratio of macrophages (P<0.05). Conclusion: miR-148b inhibits the expression of DcR3, thereby inhibiting M2 polarization in LPS-stimulated macrophage cells.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			Lipopolysaccharides/pharmacology*
		                        			;
		                        		
		                        			Macrophages
		                        			;
		                        		
		                        			MicroRNAs/genetics*
		                        			;
		                        		
		                        			Receptors, Tumor Necrosis Factor, Member 6b/metabolism*
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha
		                        			
		                        		
		                        	
3.Mechanism of "Ephedrae Herba-Descurainiae Semen Lepidii Semen" combination in treatment of bronchial asthma based on network pharmacology and experimental verification.
Bei-Bei ZHANG ; Meng-Nan ZENG ; Qin-Qin ZHANG ; Ru WANG ; Ju-Fang JIA ; Peng-Li GUO ; Meng LIU ; Wei-Sheng FENG ; Xiao-Ke ZHENG
China Journal of Chinese Materia Medica 2022;47(18):4996-5007
		                        		
		                        			
		                        			This study aims to investigate mechanism of "Ephedrae Herba-Descurainiae Semen Lepidii Semen" combination(MT) in the treatment of bronchial asthma based on network pharmacology and in vivo experiment, which is expected to lay a theoretical basis for clinical application of the combination. First, the potential targets of MT in the treatment of bronchial asthma were predicted based on network pharmacology, and the "Chinese medicine-active component-target-pathway-disease" network was constructed, followed by Gene Oncology(GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment of the potential targets. Molecular docking was used to determine the binding activity of key candidate active components to hub genes. Ovalbumin(OVA, intraperitoneal injection for sensitization and nebulization for excitation) was used to induce bronchial asthma in rats. Rats were classified into control group(CON), model group(M), dexamethasone group(DEX, 0.075 mg·kg~(-1)), and MT(1∶1.5) group. Hematoxylin and eosin(HE), Masson, and periodic acid-Schiff(PAS) staining were performed to observe the effect of MT on pathological changes of lungs and trachea and goblet cell proliferation in asthma rats. The levels of transforming growth factor(TGF)-β1, interleukin(IL)6, and IL10 in rat serum were detected by enzyme-linked immunosorbent assay(ELISA), and the mRNA and protein levels of mitogen-activated protein kinase 8(MAPK8), cyclin D1(CCND1), IL6, epidermal growth factor receptor(EGFR), phosphatidylinositol 3-kinase(PI3 K), and protein kinase B(Akt) by qRT-PCR and Western blot. Network pharmacology predicted that MAPK8, CCND1, IL6, and EGFR were the potential targets of MT in the treatment of asthma, which may be related to PI3 K/Akt signaling pathway. Quercetin and β-sitosterol in MT acted on a lot of targets related to asthma, and molecular docking results showed that quercetin and β-sitosterol had strong binding activity to MAPK, PI3 K, and Akt. In vivo experiment showed that MT could effectively alleviate the symptoms of OVA-induced asthma rats, improve the pathological changes of lung tissue, reduce the production of goblet cells, inhibit the inflammatory response of asthma rats, suppress the expression of MAPK8, CCND1, IL6, and EGFR, and regulate the PI3 K/Akt signaling pathway. Therefore, MT may relieve the symptoms and inhibit inflammation of asthma rats by regulating the PI3 K/Akt signaling pathway, and quercetin and β-sitosterol are the candidate active components.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Asthma/drug therapy*
		                        			;
		                        		
		                        			Cyclin D1
		                        			;
		                        		
		                        			Dexamethasone/adverse effects*
		                        			;
		                        		
		                        			Drug Combinations
		                        			;
		                        		
		                        			Drugs, Chinese Herbal/therapeutic use*
		                        			;
		                        		
		                        			Eosine Yellowish-(YS)/adverse effects*
		                        			;
		                        		
		                        			Ephedra
		                        			;
		                        		
		                        			ErbB Receptors
		                        			;
		                        		
		                        			Hematoxylin/therapeutic use*
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			Interleukin-6
		                        			;
		                        		
		                        			Mitogen-Activated Protein Kinase 8/therapeutic use*
		                        			;
		                        		
		                        			Molecular Docking Simulation
		                        			;
		                        		
		                        			Network Pharmacology
		                        			;
		                        		
		                        			Ovalbumin/adverse effects*
		                        			;
		                        		
		                        			Periodic Acid/adverse effects*
		                        			;
		                        		
		                        			Phosphatidylinositol 3-Kinases
		                        			;
		                        		
		                        			Proto-Oncogene Proteins c-akt/metabolism*
		                        			;
		                        		
		                        			Quercetin
		                        			;
		                        		
		                        			RNA, Messenger
		                        			;
		                        		
		                        			Rats
		                        			
		                        		
		                        	
4.CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation.
Yue-Hua HUANG ; Wei ZHANG ; Hao CAI ; Tian-Jiao LI ; Jian LI ; Bing HAN ; Jun-Ling ZHUANG ; Tie-Nan ZHU ; Hua-Cong CAI ; Dao-Bin ZHOU
Journal of Experimental Hematology 2016;24(3):815-820
BACKGROUNDCD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases, etc.
OBJECTIVETo investigate the role of CD200 and its receptor in the graft versus host disease (GVHD).
METHODSExperimental samples were divided into aGVHD group, non-aGVHD group, cGVHD group and non-cGVHD group, the healthy persons were used as normal controls. Firstly, the expression levels of CD200 and CD200R on CD19+ cell, CD3+ cell and dendritic cell (CD19- CD14- CD1c+) surfaces in each group were detected by using flow cytometry, so as to determine whether there were expression differences among each groups. Then, the mRNA levels of each groups were tested by using real-time quantitative polymerase chain reaction for finding the differences of mRNA expression level among each group. Finally, the peripheral blood mononuclear cells of the patients and healthy controls were co-cultured with anti-CD200R1 antibody for 48 hours, and the interleukin-10 level in the co-culture system was tested by using enzyme linked immunosorbent assay for verifying the function of CD200/CD200R.
RESULTSThe CD200 expression level on CD19+ cell surface in the aGVHD group and non-aGVHD group was both lower than that in healthy control group; that in the non-aGVHD group was higher than that in the aGVHD group. The CD200 expression level on CD19+ CD200+ cells in the non-cGVHD group were higher than that in the cGVHD group and healthy control group. There were no significant differences of CD200 and CD200R expression levels on CD3 cells and dendritic cells among all groups. The CD200 mRNA expression levels in the aGVHD group and cGVHD group were both lower than the healthy control group. The CD200 mRNA expression level was lower in the aGVHD group than in the non-aGVHD group, and was lower in the cGVHD group than in the non-cGVHD group. There was no significant difference of the CD200R mRNA expression level among all groups. After the peripheral blood mononuclear cells of the patients and healthy controls were co-cultured with anti-CD200R1 antibody for 48 hours, the interleukin-10 concentration decreased with the increasing of anti-CD200R1 antibody concentrations in the co-culture system.
CONCLUSIONThe CD200/CD200R may play a role in the pathogenesis of GVHD after allo-HSCT.
Antigens, CD ; metabolism ; Coculture Techniques ; Dendritic Cells ; metabolism ; Flow Cytometry ; Graft vs Host Disease ; metabolism ; Hematopoietic Stem Cell Transplantation ; Humans ; Interleukin-10 ; metabolism ; Leukocytes, Mononuclear ; Membrane Glycoproteins ; metabolism ; RNA, Messenger ; metabolism ; Receptors, Cell Surface ; metabolism ; Transplantation, Homologous
5.Expressions of SP and NK-1R increase in the posterior horn of the L5-S2 spinal cord in rats with chronic nonbacterial prostatitis.
Li-Ya HAO ; Li LIU ; Xian-Guang BAI ; Xin-Hua ZHENG
National Journal of Andrology 2016;22(7):602-607
ObjectiveTo investigate the expressions of substance P (SP) and neurokinin-1 receptor (NK-1R) in the posterior horn of the L5-S2 spinal cord in the rat model of chronic nonbacterial prostatitis (CNP) at different time points of modeling.
METHODSForty adult male SD rats were randomly divided into four groups of equal number, control, 45 d model, 60 d model, and 90 d model, and proteins were obtained from the prostatic tissue of another 30 rats. The CNP model was made by intraperitoneal injection of 0.5 ml DPT vaccineand intradermal injection of mixed solution of 1 ml prostatein extract and complete adjuvant at a 1∶1 ratio, while the control rats were injected with the same volume of normal saline. At 45, 60, and 90 days after modeling, we measured the paw withdrawal threshold (PWT) of the rats, determined the levels of TNF-α, IL-1β, IL-2, and IL-10 in the prostate tissue by ELISA, observed the histomorphological changes in the prostate by transmission electron and light microscopy, and detected the expressions of SP and NK1-R in the L5-S2 spinal cord by immunohistochemistry.
RESULTSThe model rats showed significantly increased sensitivity to pain, with remarkably lowered PWT at 45, 60, and 90 days after modeling. The levels of TNF-α, IL-1β, IL-2, and IL-10 in the prostate tissue were markedly elevated in the CNP models as compared with those in the controls (all P<0.05), most significantly at 90 days (all P<0.05). Immunohistochemistry showed that the expressions of SP and NK-1R were remarkably higher in the CNP model groups than in the control (all P<0.05), the highest at 90 days. Light microscopy revealed no inflammatory cell infiltration in the prostate tissue of the control rats, and obvious edema and increased lymphocytes were observed with the prolonged time of modeling.Transmission electron microscopy showed inflammatory changes in the prostate tissue of the model rats and that peritubular interstitial edema was most obvious at 90 days, with widened intervals between peritubular cells and the epithelial base and increased numbers of fibroblasts and collagen fibrils.
CONCLUSIONSThe synthesis of SP and the level of NK-1R were increased in the posterior horn of the L5-S2 spinal cord in the rat model of CNP.
Animals ; Interleukin-10 ; metabolism ; Interleukin-1beta ; metabolism ; Interleukin-2 ; metabolism ; Male ; Pain ; Prostatitis ; metabolism ; physiopathology ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Neurokinin-1 ; metabolism ; Spinal Cord ; metabolism ; Substance P ; metabolism ; Tumor Necrosis Factor-alpha ; metabolism
6.The effect of signal transduction pathway of triggering receptor-1 expressed on myeloid cells in acute lung injury induced by paraquat in rats.
Ming WEI ; Ling TU ; E-mail: TULING@126.COM. ; Yinghong LIANG ; Jia LIU ; Yanjie GONG ; Diming XIAO ; Yihua ZHANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2015;33(9):646-651
OBJECTIVETo investigate the transduction pathway of triggering receptor-1 expressed on myeloid cells (TREM-1) in acute lung injure induced by paraquat in rats through the activating or blocking TREM-1, to observe the effect of signal transduction pathway in the acute lung injure induced-paraquat.
METHODS80 SD rats were randomly divided into normal saline control group (n=20) , PQ poisoning group (n=20) , antibody group (n=20) , and LP17 group (n=20). poisoning group, antibody group and LP17 group were given saline diluting PQ 80 mg/kg of disposable lavage after 2 h, a single set of intraperitoneal injection of anti-TREM-1 mAb (250 g/kg) , tail intravenous LP17 group synthetic peptide (3.5 mg/kg) , poisoning group was given equal normal saline intraperitoneal injection, control group given normal saline 1 mg/kg after 2 h after lavage, given the amount of intraperitoneal injection of saline solution. The expression of NF-κB in lung tissue was determined by immunohistochemistry.The levels of TNF-a, IL-10, TREM-1, and soluble TREM-1 (sTREM-1) in lung tissue and serum were measured by ELISA. Pathology changes of lung were observed under light microscope, and lung score of pathology was compared.
RESULTSAdministration of anti-TREM-1 mAb after PQ poisoning modeling significantly increased the NF-κB expression in lung tissue at 48 h, resulting in a large number of pro-inflammatory cytokines releasing in the lung tissue and serum and lung pathology injury score increasing.Administration of LP17 after modeling significantly down-·regulated the expressions of NF-κB and proinflammatory cytokines, while led to a slight increase of anti-inflammatory cytokines and a decline of lung pathology injury score.
CONCLUSIONTREM-1 may involve in inflammatory response by promoting the generation of inflammatory factors via NF-κB pathway, thus lead to lung pathological changes.
Acute Lung Injury ; chemically induced ; metabolism ; Animals ; Interleukin-10 ; metabolism ; NF-kappa B ; metabolism ; Paraquat ; toxicity ; Rats ; Rats, Sprague-Dawley ; Receptors, Immunologic ; metabolism ; Signal Transduction ; Triggering Receptor Expressed on Myeloid Cells-1 ; Tumor Necrosis Factor-alpha ; metabolism
7.Toll-Like Receptor Gene Expression during Trichinella spiralis Infection.
Sin KIM ; Mi Kyung PARK ; Hak Sun YU
The Korean Journal of Parasitology 2015;53(4):431-438
		                        		
		                        			
		                        			In Trichinella spiralis infection, type 2 helper T (Th2) cell-related and regulatory T (T(reg)) cell-related immune responses are the most important immune events. In order to clarify which Toll-like receptors (TLRs) are closely associated with these responses, we analyzed the expression of mouse TLR genes in the small intestine and muscle tissue during T. spiralis infection. In addition, the expression of several chemokine- and cytokine-encoding genes, which are related to Th2 and T(reg) cell mediated immune responses, were analyzed in mouse embryonic fibroblasts (MEFs) isolated from myeloid differentiation factor 88 (MyD88)/TIR-associated proteins (TIRAP) and Toll receptor-associated activator of interferons (TRIF) adapter protein deficient and wild type (WT) mice. The results showed significantly increased TLR4 and TLR9 gene expression in the small intestine after 2 weeks of T. spiralis infection. In the muscle, TLR1, TLR2, TLR5, and TLR9 gene expression significantly increased after 4 weeks of infection. Only the expression of the TLR4 and TLR9 genes was significantly elevated in WT MEF cells after treatment with excretory-secretory (ES) proteins. Gene expression for Th2 chemokine genes were highly enhanced by ES proteins in WT MEF cells, while this elevation was slightly reduced in MyD88/TIRAP-/- MEF cells, and quite substantially decreased in TRIF-/- MEF cells. In contrast, IL-10 and TGF-beta expression levels were not elevated in MyD88/TIRAP-/- MEF cells. In conclusion, we suggest that TLR4 and TLR9 might be closely linked to Th2 cell and T(reg) cell mediated immune responses, although additional data are needed to convincingly prove this observation.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Gene Expression
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Interleukin-10/genetics
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Knockout
		                        			;
		                        		
		                        			Th2 Cells/metabolism
		                        			;
		                        		
		                        			Toll-Like Receptors/*genetics/metabolism
		                        			;
		                        		
		                        			Trichinella spiralis/genetics/*physiology
		                        			;
		                        		
		                        			Trichinellosis/genetics/metabolism/*parasitology
		                        			
		                        		
		                        	
8.The role of Nods like receptors in the patients with allergic rhinitis.
Shenhua ZHANG ; Yanhui LIU ; Congxiang SHEN ; Guanxue LI ; Keke YANG ; Xin SHI ; Zhong WEN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(15):1323-1328
		                        		
		                        			OBJECTIVE:
		                        			To explore role of Nods (nucleotide-binding oligomerization domain Nod Like receptors) kind of pattern recognition receptors (PRR) in patients with allergic rhinitis.
		                        		
		                        			METHOD:
		                        			The mRNA and protein of Nod1, Nod2 of Nalp3 were analyzed in the turbinate mucosa of patients with allergic rhinitis, nasal septum deviation (NSD) nasal mucosa of patients and nasal polyp mucosa with Real-Time RT-PCR, Western blot and immunohistochemistry respectively, and Nod1 expression changes was explored in PBMC with wad explored Western-blot and then the level of IL-4, IL-6, IL-10, IFN-γ were detected in serum of AR after desensitization treatment.
		                        		
		                        			RESULT:
		                        			These Nods like receptors, mainly found in nasal mucosa epithelial cells, glandular epithelium and inflammatory cells (e. g. plasma cells, eosinophils), were expressed in the nasal mucosa tissues. In AR group, Nod1 (mRNA and protein) expression were lower than NSD group (P<0.05), Nalp3 expression were higher than (P<0.05), while, there was no significant difference of Nod2 (mRNA and protein) between groups. After 6 months desensitization therapy, the change of Nod1 in PBMC was negatively correlated with the change of IL-10 in the peripheral blood, r=-0.88, P<0.05; while, change of Nod1 was positively correlated, with the change of IL-6, r=0.57, P>0.05.
		                        		
		                        			CONCLUSION
		                        			Nod1, Nod2 and Nalp3 expression were seen in the two groups,and the Nod1 expression in allergic rhinitis group was lower than other two groups, while, the Nalp3 was higher than other two groups. It showed Nod1, Nalp3 may be involved in the pathogenesis of allergic rhinitis. Expression of Nod1 in PBMC reduced after sublingual desensitization treatment. Besides, the change of Nod1 was negatively correlated with the change of IL-10 in PBMC. So,it seemed that Nod1 may regulate IL-10 changes and be involved in sublingual desensitization therapy.
		                        		
		                        		
		                        		
		                        			Carrier Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Interferon-gamma
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			Interleukin-4
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			Interleukin-6
		                        			;
		                        		
		                        			blood
		                        			;
		                        		
		                        			Leukocytes, Mononuclear
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			NLR Family, Pyrin Domain-Containing 3 Protein
		                        			;
		                        		
		                        			Nasal Mucosa
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Nasal Polyps
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Nod1 Signaling Adaptor Protein
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Nod2 Signaling Adaptor Protein
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Receptors, Pattern Recognition
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Rhinitis, Allergic
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Turbinates
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
9.Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet.
Hye Sook MIN ; Jung Eun KIM ; Mi Hwa LEE ; Hye Kyoung SONG ; Mi Jin LEE ; Ji Eun LEE ; Hyun Wook KIM ; Jin Joo CHA ; Young Youl HYUN ; Jee Young HAN ; Dae Ryong CHA ; Young Sun KANG
Kidney Research and Clinical Practice 2014;33(1):33-44
		                        		
		                        			
		                        			BACKGROUND: Obesity-related metabolic disorders are closely associated with inflammation induced by innate immunity. Toll-like receptors (TLRs) play a pivotal role in the innate immune system by activating proinflammatory signaling pathways. GIT27 (4,5-dihydro-3-phenyl-5-isoxasole acetic acid) is an active immunomodulatory agent that primarily targets macrophages and inhibits secretion of tumor necrosis factor alpha [as well as interleukin (IL)-1beta, IL-10, and interferon gamma]. However, the effect of TLR antagonist on kidney diseases has rarely been reported. We investigated whether the TLR antagonist GIT27 has beneficial effects on the progression of kidney disease in obese mice on a high-fat diet (HFD). METHODS: Six-week-old male C57BL/6 mice were divided into three groups: mice fed with normal chow diet (N=4); mice fed with a HFD (60% of total calories from fat, 5.5% from soybean oil, and 54.5% from lard, N=4); and GIT27-treated mice fed with a HFD (N=7). RESULTS: Glucose intolerance, oxidative stress, and lipid abnormalities in HFD mice were improved by GIT27 treatment. In addition, GIT27 treatment decreased the urinary excretion of albumin and protein in obesity-related kidney disease, urinary oxidative stress markers, and inflammatory cytokine levels. This treatment inhibited the expression of proinflammatory cytokines in the kidneys and adipose tissue, and improved extracellular matrix expansion and tubulointerstitial fibrosis in obesity-related kidney disease. CONCLUSION: TLR inhibition by administering GIT27 improved metabolic parameters. GIT27 ameliorates abnormalities of lipid metabolism and may have renoprotective effects on obesity-related kidney disease through its anti-inflammatory properties.
		                        		
		                        		
		                        		
		                        			Acetic Acid*
		                        			;
		                        		
		                        			Adipose Tissue
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cytokines
		                        			;
		                        		
		                        			Diet
		                        			;
		                        		
		                        			Diet, High-Fat*
		                        			;
		                        		
		                        			Extracellular Matrix
		                        			;
		                        		
		                        			Fibrosis
		                        			;
		                        		
		                        			Glucose Intolerance
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immune System
		                        			;
		                        		
		                        			Immunity, Innate
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Interferons
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			Interleukins
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Kidney Diseases*
		                        			;
		                        		
		                        			Lipid Metabolism
		                        			;
		                        		
		                        			Macrophages
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mice*
		                        			;
		                        		
		                        			Mice, Obese
		                        			;
		                        		
		                        			Obesity
		                        			;
		                        		
		                        			Oxidative Stress
		                        			;
		                        		
		                        			Soybean Oil
		                        			;
		                        		
		                        			Toll-Like Receptors*
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha
		                        			
		                        		
		                        	
10.Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy.
Jia HE ; Xiao-Feng TANG ; Qiu-Yan CHEN ; Hai-Qiang MAI ; Zhou-Feng HUANG ; Jiang LI ; Yi-Xin ZENG
Chinese Journal of Cancer 2012;31(6):287-294
		                        		
		                        			
		                        			Establishing Epstein-Barr virus(EBV)-specific cytolytic T lymphocytes(EBV-CTLs) from peripheral blood mononuclear cells(PBMCs) for adoptive immunotherapy has been reported in EBV-associated malignancies including Hodgkin's lymphoma and nasopharyngeal carcinoma(NPC). In the current study, we performed ex vivo expansion of tumor-infiltrating lymphocytes(TILs) obtained from NPC biopsy specimens with a rapid expansion protocol using anti-CD3 monoclonal antibody(OKT3), recombinant human interleukin(IL)-2, and irradiated PBMCs from healthy donors to initiate the growth of TILs. Young TIL cultures comprised of more than 90% of CD3+ T cells, a variable percentage of CD3+CD8+ and CD3+CD4+ T cells, and less than 10% of CD3-CD16+ natural killer cells, a similar phenotype of EBV-CTL cultures from PBMCs. Interestingly, TIL cultures secreted high levels of the Th1 cytokines, interferon gamma (IFNγ) and tumor necrosis factor-alpha (TNF-α), and low levels of the Th2 cytokines, IL-4 and IL-10. Moreover, young TILs could recognize autologous EBV-transformed B lymphoblast cell lines, but not autologous EBV-negative blast cells or allogeneic EBV-negative tumor cells. Taken together, these data suggest that ex vivo expansion of TILs from NPC biopsy tissue is an appealing alternative method to establish T cell-based immunotherapy for NPC.
		                        		
		                        		
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			CD3 Complex
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			CD4 Antigens
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			CD8 Antigens
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			Cells, Cultured
		                        			;
		                        		
		                        			Herpesvirus 4, Human
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunotherapy, Adoptive
		                        			;
		                        		
		                        			Interferon-gamma
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Interleukin-2
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Interleukin-4
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Lymphocytes, Tumor-Infiltrating
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Monocytes
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Muromonab-CD3
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Nasopharyngeal Neoplasms
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Receptors, IgG
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			T-Lymphocytes, Cytotoxic
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail